Literature DB >> 18661339

Dysregulation of matrix metalloproteinases and their tissue inhibitors by S100A4.

Renate Elenjord1, Hilde Ljones, Elisabeth Sundkvist, Thrina Loennechen, Jan Olof Winberg.   

Abstract

The S100A4 protein as well as the matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are associated with diseases such as arthritis and cancer. This mini review focuses on in vitro and in vivo studies indicating S100A4 involvement in regulation of MMPs and TIMPs, and the biological and pathobiological consequences of this regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18661339     DOI: 10.1080/03008200802143125

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  8 in total

1.  S100A4 expression in xenograft tumors of human carcinoma cell lines is induced by the tumor microenvironment.

Authors:  Hilde Ljones Wetting; Elin Hadler-Olsen; Synnøve Magnussen; Oddveig Rikardsen; Sonja E Steigen; Elisabeth Sundkvist; Thrina Loennechen; Premasany Kanapathippillai; Hanne Kildalsen; Jan-Olof Winberg; Lars Uhlin-Hansen; Gunbjørg Svineng
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Metastasin S100A4 is a mediator of sex hormone-dependent formation of the cortical bone.

Authors:  Malin C Erlandsson; Li Bian; Ing-Marie Jonsson; Karin M Andersson; Maria I Bokarewa
Journal:  Mol Endocrinol       Date:  2013-06-24

3.  Nifedipine and phenytoin induce matrix synthesis, but not proliferation, in intact human gingival connective tissue ex vivo.

Authors:  Shawna S Kim; Sarah Michelsons; Kendal Creber; Michael J Rieder; Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2015-08-23       Impact factor: 5.782

Review 4.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

5.  Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation.

Authors:  Mathias Dahlmann; Ulrike Sack; Pia Herrmann; Margit Lemm; Iduna Fichtner; Peter M Schlag; Ulrike Stein
Journal:  Oncotarget       Date:  2012-08

6.  Shotgun Proteomics for the Identification and Profiling of the Tear Proteome of Keratoconus Patients.

Authors:  Maite López-López; Uxía Regueiro; Susana Belén Bravo; María Del Pilar Chantada-Vázquez; Carmen Pena; Elío Díez-Feijoo; Pablo Hervella; Isabel Lema
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-05-02       Impact factor: 4.925

Review 7.  S100 Proteins in Fatty Liver Disease and Hepatocellular Carcinoma.

Authors:  Etienne Delangre; Ezia Oppliger; Serkan Berkcan; Monika Gjorgjieva; Marta Correia de Sousa; Michelangelo Foti
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

8.  MiR-296-5p ameliorates deep venous thrombosis by inactivating S100A4.

Authors:  Zhichang Pan; Yu Zhang; Chuanyong Li; Yuan Yin; Rui Liu; Guangfeng Zheng; Weijian Fan; Qiang Zhang; Zhenyu Song; Ziyue Guo; Jianjie Rong; Yixin Shen
Journal:  Exp Biol Med (Maywood)       Date:  2021-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.